Skip to content

BABA Robotic Thyroidectomy Without Gas is Safe Enough as That Use a Gas

A Prospective, Randomized, and Controlled Study of the Safety and Efficacy in Gasless BABA(Bilateral Axillo-breast Approach) Robotic Thyroidectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03922282
Enrollment
28
Registered
2019-04-19
Start date
2018-01-03
Completion date
2018-10-08
Last updated
2019-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Diseases, Thyroidectomy

Keywords

Gasless, Bilateral axillo-breast approach, Da Vinci, Robot-assisted thyroid surgery

Brief summary

In this study, a randomized controlled study was conducted between two groups of 14 classic recipients of Carbon dioxide insufflation during BABA robotic-thyroidectomy and 14 recipients of Gasless method during BABA robotic-thyroidectomy. This is a study to see if there is any difference in hemodynamic and metabolic changes and pain .

Interventions

PROCEDUREGasless BABA

BABA robotic-thyroidectomy that is using elevation of flap instead of using carbon dioxide.

PROCEDUREClassic BABA

BABA robotic-thyroidectomy that is using carbon dioxide.

Sponsors

Inje University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Subject who will have thyroid surgery

Exclusion criteria

* Subject who underwent thyroid surgery * Subject who underwent any radiotherapy on neck * Subject who need to neck dissection * Subject under 18 years or over 70 years * Bad general condition * High American Society of Anesthesiologists(ASA) score (over 3) * Breast feeder or pregnancy * Subject who disagree to do this trial

Design outcomes

Primary

MeasureTime frameDescription
heart rateChange from baseline heart rate at the end of surgeryheart rate in beats per minute
mean arterial pressureChange from baseline mean arterial pressure at the end of surgerymean arterial pressure in mmHg
cardiac indexChange from baseline cardiac index at the end of surgerycardiac index in L/min/m\^2, divide the cardiac output by the person's body surface area, measured by the Vigileo monitor, normal range is 2.5 to 4.5L/min/m2
cardiac outputChange from baseline cardiac output at the end of surgerycardiac output in L/minute, calculated by multiplying the stroke volume by the heart rate, measured by the Vigileo monitor
pHChange from baseline pH at the end of surgerypH
PaCO2Change from baseline PaCO2 at the end of surgeryPaCO2 in mmHg
VAS(visual analog score)change from baseline VAS up to 3days after surgeryVisual Analog Score for pain, range from 0 to 10, Higher the values represents more pains
BHC(bottom hit count)change from baseline BHC up to 3days after surgerybottom hit count from intravenous patient controlled analgesia for pain
number of analgesicschange from baseline number of analgesics up to 3days after surgerynumber of analgesics(additional ketorolac uses)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026